Please note - this trial is no longer recruiting patients. We hope to add results when they are available. If the AZURE trial finds that zoledronic acid lowers the risk of the cancer coming back, it ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback